MENU
GDTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CytoMed Therapeutics (GDTC) Earnings Date & Reports

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

A.I. Advisor
published Earnings

GDTC is expected to report earnings to fall 78.95% to -3 cents per share on December 03

CytoMed Therapeutics GDTC Stock Earnings Reports
Q3'25
Est.
$-0.04
Q2'25
Missed
by $0.15
Q4'24
Missed
by $0.08
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.01
The last earnings report on October 02 showed earnings per share of -18 cents, missing the estimate of -3 cents. With 27.71K shares outstanding, the current market capitalization sits at 22.76M.
View a ticker or compare two or three
GDTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GDTC showed earnings on October 02, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
28
Web
https://w2.cytomed.sg